Faced with an aging population and poised to be overtaken by India as the world’s most populous country, China continues to struggle to boost its birth rate.
The French drugmaker is the last major insulin manufacturer to try to head off government efforts to cap monthly costs by announcing its own steep price cuts.
Winter is on the way, and in war-torn Ukraine the fight against Russia appears far from over.
While there was a shortage of containers at the height of the pandemic, the global economy is now facing the opposite problem: too many containers.